---
title: "MPS Pharmaa Ltd (531686) — Share Price, Financials & Analysis"
symbol: "531686"
company: "MPS Pharmaa Ltd"
canonical: "https://tapetide.com/stocks/531686"
isin: "INE537C01019"
bse_code: "531686"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 3.8
generated_at: "2026-09-13T19:09:40.751Z"
---

# MPS Pharmaa Ltd (531686)

Canonical page: https://tapetide.com/stocks/531686

## Company

- **BSE Code:** 531686
- **ISIN:** INE537C01019
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2006-03-01
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** advikindia.com

## About

Incorporated in 1997, MPS Pharmaa Ltd manufactures and sells pharmaceutical 
products[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-07T04:34:02.421981Z.

- **Market Cap:** ₹3.8 Cr
- **Classification:** Microcap
- **P/E (reported):** -3.7
- **EPS (TTM):** ₹-0.56
- **Book Value:** ₹0.04
- **Price to Book:** 53.27
- **Dividend Yield:** 0%
- **ROE:** -83.08%
- **ROCE:** -68.25%
- **Debt to Equity:** 107.43
- **Revenue (yearly):** ₹0 Cr
- **Net Income:** ₹-1.06 Cr
- **EBITDA:** ₹-0.95 Cr
- **52-Week High:** ₹2.08
- **52-Week Low:** ₹1.57

## Key Insights

### Weaknesses

- Stock is trading at 54.3 times its book value
- Company has low interest coverage ratio.
- Promoter holding is low: 35.9%
- Company has a low return on equity of -61.4% over last 3 years.
- Company might be capitalizing the interest cost

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 9.52% | 34.48% | 38.71% |
| ebitda margin growth | 33.33% | -100% | -100% | -100% |
| net income growth | 50% | 17.78% | 1% | 12% |
| revenue growth | 0% | — | -100% | -100% |
| roce | — | 75.63% | 92.42% | -52.45% |
| roe | — | 96.83% | -54.31% | -25.68% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.21 | 0.18 | 0.21 | 0.19 | 0.19 | 0.18 | 0.19 | 0.19 | 0.19 | 0.19 | 0.37 | 0.2 |
| Operating Profit | -0.21 | -0.18 | -0.21 | -0.19 | -0.19 | -0.18 | -0.19 | -0.19 | -0.19 | -0.19 | -0.37 | -0.2 |
| Other Income | 0.06 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0.04 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Profit before tax | -0.19 | -0.22 | -0.25 | -0.23 | -0.23 | -0.18 | -0.23 | -0.23 | -0.23 | -0.23 | -0.37 | -0.24 |
| Tax % | -5.26 | -4.55 | 0 | -4.35 | -4.35 | 0 | 21.74 | -4.35 | -4.35 | -4.35 | -2.7 | 0 |
| Net Profit | -0.18 | -0.21 | -0.24 | -0.22 | -0.22 | -0.17 | -0.28 | -0.22 | -0.22 | -0.22 | -0.36 | -0.24 |
| EPS in Rs | -0.09 | -0.11 | -0.13 | -0.12 | -0.12 | -0.09 | -0.15 | -0.12 | -0.12 | -0.12 | -0.19 | -0.13 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 4.09 | 0.83 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 4.62 | 1.56 | 0.67 | 4.14 | 0.71 | 0.95 | 0.8 | 0.77 | 0.95 | 0.95 |
| Operating Profit | -0.53 | -0.73 | -0.67 | -4.14 | -0.68 | -0.95 | -0.8 | -0.77 | -0.95 | -0.95 |
| OPM % | -12.96 | -87.95 | — | — | -2266.67 | — | — | — | — | — |
| Other Income | 0.06 | 0.02 | 0.01 | 0.2 | 0.26 | 0.02 | 0.09 | 0.05 | 0.04 | 0.04 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.59 | 0.59 | 0.57 | 0.56 | 0.51 | 0.15 | 0.15 | 0.15 | 0.15 | 0.16 |
| Profit before tax | -1.06 | -1.3 | -1.23 | -4.5 | -0.93 | -1.08 | -0.86 | -0.87 | -1.06 | -1.07 |
| Tax % | -17.92 | -3.85 | -5.69 | -1.78 | -84.95 | -1.85 | -2.33 | 3.45 | -3.77 | — |
| Net Profit | -0.87 | -1.25 | -1.17 | -4.42 | -0.14 | -1.05 | -0.83 | -0.9 | -1.02 | -1.04 |
| EPS in Rs | -0.46 | -0.65 | -0.61 | -2.31 | -0.07 | -0.55 | -0.43 | -0.47 | -0.53 | -0.56 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 |
| Reserves | -7.5 | -8.35 | -9.58 | -10.75 | -15.16 | -15.29 | -16.32 | -17.14 | -18.03 | -19.04 |
| Borrowings | 2.9 | 2.9 | 2.51 | 2.53 | 5.68 | 5.81 | 6.77 | 7.27 | 7.46 | 7.52 |
| Other Liabilities | 6.41 | 5.49 | 5.52 | 5.52 | 1.67 | 0.53 | 0.63 | 0.7 | 0.8 | 0.89 |
| Total Liabilities | 20.92 | 19.15 | 17.56 | 16.41 | 11.3 | 10.16 | 10.19 | 9.94 | 9.34 | 8.48 |
| Fixed Assets | 7.06 | 6.47 | 5.88 | 5.26 | 4.68 | 4.17 | 4.14 | 4.01 | 3.83 | 3.66 |
| CWIP | 5.51 | 5.21 | 5.43 | 5.02 | 3.9 | 3.42 | 3.4 | 3.26 | 2.91 | 2.41 |
| Investments | 0.92 | 0.92 | 0.92 | 0.92 | 0.54 | 0.54 | 0.54 | 0.54 | 0.54 | 0.54 |
| Other Assets | 7.43 | 6.55 | 5.33 | 5.21 | 2.18 | 2.03 | 2.11 | 2.13 | 2.06 | 1.87 |
| Total Assets | 20.92 | 19.15 | 17.56 | 16.41 | 11.3 | 10.16 | 10.19 | 9.94 | 9.34 | 8.48 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.37 | -0.34 | 0.61 | -0.49 | -0.93 | -4.34 | -0.87 | -0.63 | -0.57 | -0.59 |
| Cash from Investing Activity | 0.63 | 0.3 | -0.22 | 0.46 | 1.54 | 0.46 | -0.1 | 0.12 | 0.38 | 0.52 |
| Cash from Financing Activity | -0.98 | 0 | -0.39 | 0.03 | -0.61 | 3.88 | 0.96 | 0.51 | 0.18 | 0.07 |
| Net Cash Flow | 0.02 | -0.04 | 0 | 0 | 0 | 0 | -0.01 | 0 | 0 | 0 |
| Free Cash Flow | 1 | -0.04 | 0.39 | -0.04 | 0.22 | -3.88 | -0.97 | -0.51 | -0.19 | -0.07 |
| CFO/OP | -5 | 64 | -84 | 73 | 22 | 638 | 92 | 79 | 74 | 62 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 532.08 | 344.47 | 1147.77 | — | — | 365 | — | — | — | — |
| Inventory Days | 50.05 | 58.94 | 253.72 | — | — | 4015 | 4562.5 | — | — | — |
| Days Payable | 15.95 | 14.48 | 71.22 | — | — | 876 | 1825 | — | — | — |
| Cash Conversion Cycle | 566.19 | 388.94 | 1330.27 | — | — | 3504 | — | — | — | — |
| Working Capital Days | -115.67 | -87.46 | -848.73 | — | — | -49396.67 | — | — | — | — |
| ROCE % | -37.07 | -7.53 | -10.12 | -10.73 | -45.61 | -9.66 | -11.26 | -9.15 | -9.79 | -13.14 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 35.89% | 35.89% | 35.89% | 35.89% | 35.89% | 35.89% | 35.89% | 35.89% | 35.89% | 35.89% | 35.89% | 35.89% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.58% | 0% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 36.27% | 36.19% | 36.06% | 35.97% | 36.05% | 36.68% | 36.78% | 37.07% | 37.11% | 37.12% | 37.94% | 37.94% |
| Others | 27.27% | 27.92% | 27.47% | 27.56% | 27.48% | 26.85% | 26.75% | 26.46% | 26.42% | 26.41% | 25.59% | 25.59% |
| No. of Shareholders | 4454 | 4435 | 4414 | 4398 | 4386 | 4397 | 4422 | 4445 | 4433 | 4425 | 4419 | 4409 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 7 / 2 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1.89 | Buy |
| EMA (10) | 1.9 | Buy |
| SMA (20) | 1.8 | Buy |
| EMA (20) | 1.87 | Buy |
| SMA (50) | 1.99 | Sell |
| EMA (50) | 2.09 | Sell |
| SMA (100) | 2.81 | Sell |
| EMA (100) | 2.36 | Sell |
| SMA (200) | 2.51 | Sell |
| EMA (200) | 2.33 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 61.38 | Neutral |
| MACD (12,26,9) | 0 | Buy |
| Stochastic (14,3,3) | 100 | Sell |
| ADX (14) | 28.37 | Buy |
| Williams %R (14) | 0 | Sell |
| ATR (14) | 0.04 | Neutral |
| ROC (12) | 15.03 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 94.91 | Sell |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Notice Of Book Closure](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a26da772-31ea-4c1f-8a39-714fd6ec0a2e.pdf) |
| 2026-09-07 | [Notice Of Book Closure](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c97f4d45-80fb-4f77-9f73-995e60d74dae.pdf) |
| 2026-09-06 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94145a35-38b1-4e0d-b388-086e8545deac.pdf) |
| 2026-09-05 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5ac3348-79ad-4ec4-aa8b-a51f260c19ad.pdf) |
| 2026-09-05 | [Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Web Link QR Code And Navigation Path For Accessing The Annual Report For FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=365f7e59-f7a3-426e-97bb-ca81df92e9df.pdf) |
| 2026-09-05 | [Notice Of The 32Nd Annual General Meeting For The Financial Year 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1410294-a96d-42cf-ba9d-9e5fbf4c06ab.pdf) |
| 2026-09-02 | [Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Read With Schedule III Of The SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d022645-5535-4322-901a-c0644b98b213.pdf) |
| 2026-09-02 | [Shareholder Meeting- AGM To Be Held On 29Th September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=601bfb2b-cfe0-4f84-9753-c6fee97d7b80.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ebb7703-ae0d-4c32-81d6-ab3839d475a2.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4862b7d-c12a-4dcf-9277-ef1e40c568fd.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Submission Of Outcome Of Board Meeting And Unaudited Results For The Quarter Ended 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d9897d1-5185-4d5c-a0f6-8519445c5f85.pdf) |
| 2026-05-28 | [SUBMISSION OF AUDITED FINANCIAL RESULTS FOR THE F.Y. ENDED 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b6bdafb-bde1-4945-bc1d-de7ae81c73ab.pdf) |
| 2026-02-02 | [Submission Of Standalone Un-Audited Financial Results For The Quarter & Nine Months Ended 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcc09653-922c-4a79-9c56-13ed3578327a.pdf) |
| 2025-11-14 | [Results As On 30.09.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3cdd4c4-fd99-4370-bb7d-6ef59f3dfe44.pdf) |
| 2025-08-12 | [Submission Of Standalone Un-Audited Financial Results For The Quarter Ended 30Th June 2025 As Required U/R 33 Of The SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=253956de-d930-41ad-869b-c652d4497d8e.pdf) |
| 2025-05-28 | [Submission Of Audited Financial Results For The Quarter And Financial Year Ended 31Stmarch 2025 As Required U/R 33 Of The SEBI (LODR) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca116058-bfad-48a5-9ba3-a14eb6682624.pdf) |
| 2025-02-12 | [Submission Of Un-Audited Financial Results For The Quarter Ended 31St December 2024 As Required U/R 33 Of The SEBI (LODR) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31785bb6-1bac-4c49-ad19-641520d8d56a.pdf) |
| 2024-11-14 | [Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter AndHalf Year Ended 30Th September 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd42e14a-6b01-43d9-8b13-9c781ddbd103.pdf) |
| 2024-11-14 | [Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d0c5a19-288c-4040-bcac-e108dbf54f2a.pdf) |
| 2024-11-14 | [Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52bf5733-9f1c-48da-91a5-d450ab4a7ea8.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - ICRA assigned AA-(Stable) to Rs250 crore term loan; A1+ to Rs5 crore overdraft and Rs4 crore BG. | [Announcement under Regulation 30 (LODR)-Credit Rating 9h - ICRA assigned AA-(Stable) to Rs250 crore term loan; A1+ to Rs5 crore overdraft and Rs4 crore BG.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/131a7ec7-9a02-4a73-bdbe-78f57bf1a398.pdf) |
| 5 Feb - Q3 & 9M FY26 Earnings Conference Call - Transcript | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 5 Feb - Q3 & 9M FY26 Earnings Conference Call - Transcript](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b2b2e8c3-f4d9-4fab-a655-3de5894f7086.pdf) |
| 4 Feb - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR) Regulations 2015. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 Feb - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR) Regulations 2015.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/62e6be75-5e67-429b-8cf7-1e5f47ef7a9c.pdf) |
| 31 Jan - Revised Investor Presentation for the quarter and nine months ended December 31,2025. | [Announcement under Regulation 30 (LODR)-Investor Presentation 31 Jan - Revised Investor Presentation for the quarter and nine months ended December 31,2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/438b0112-d6c1-4a09-9b7e-c6b692b38d96.pdf) |
| 3 Mar - Board approved permanent retrenchment of 10 factory workers effective 02.04.2026; pivot to Ayurvedic/Unani/Homeopathic and nutraceutical products. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Outcome Of The Board Meeting 3 Mar - Board approved permanent retrenchment of 10 factory workers effective 02.04.2026; pivot to Ayurvedic/Unani/Homeopathic and nutraceutical products.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fcf77b37-539e-4626-9c45-b4e786e1f81f.pdf) |
| 3 Mar - Approved permanent retrenchment of 10 workers effective 02.04.2026; pivot to Ayurvedic/Unani/Homeopathic nutraceuticals. | [Board Meeting Outcome for Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Outcome Of The Board Meeting 3 Mar - Approved permanent retrenchment of 10 workers effective 02.04.2026; pivot to Ayurvedic/Unani/Homeopathic nutraceuticals.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d72ad058-8107-40bb-a825-48b007b2c3a1.pdf) |
| 3 Feb - Submission of newspaper publication w.r.t un-audited financial results for the quarter & nine months ended 31.12.2025 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 3 Feb - Submission of newspaper publication w.r.t un-audited financial results for the quarter & nine months ended 31.12.2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/01eb7420-d07a-44c9-a3a4-a3d15d86c5b7.pdf) |
| 27 Feb - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR) Regulations 2015. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 27 Feb - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR) Regulations 2015.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/78f2ccc7-497c-4ad3-973a-3cf298d00240.pdf) |
| 25 Mar - Independent Directors meeting on 25-Mar-2026 reviewed board/director performance and information flow. | [Board Meeting Outcome for Outcome Of Independent Director 25 Mar - Independent Directors meeting on 25-Mar-2026 reviewed board/director performance and information flow.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8b4f5b5a-8f24-4dd7-bd65-2ac631845f9f.pdf) |
| 24 Jan - Submitted Regulation 74(5) certificate for quarter ended 31-Dec-2025; RTA MAS Services confirmed dematerialisation processing. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 24 Jan - Submitted Regulation 74(5) certificate for quarter ended 31-Dec-2025; RTA MAS Services confirmed dematerialisation processing.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/98c63482-40f6-4685-9774-54f0f61d6591.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2023 | [Concall - Oct 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2dc13a13-36b5-4deb-a32a-a2ee1bfd743b.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/684edcac-492d-44b3-a47a-97d8501818c5.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d6c4e23e-64e1-4f34-9ae3-6a00b3bef567.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4ad45035-d24c-47e5-a63c-0b10b4c9c3ef.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6cae43f0-a009-4601-bd91-04cd41b70f82.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/531d3208-a647-458a-a6d1-e2b9d15fc011.pdf) |
| Jan 2026 | [Concall - Jan 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fee6e792-8a1b-46b5-bebf-38bed7e99af5.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9930589a-7ef6-4b2a-972c-f89ec62c9c79.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3d582aa0-f658-409d-a7df-a4062d880d59.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/492e615d-8880-4cbb-bb35-944da307d708.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e32a47dd-3f2a-4d61-838b-8eb4dcc21626.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9a17428e-edcf-43d7-8eda-21943be0ad15.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/81e58ed4-daa0-46b0-8bf1-e9614ba20101.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3ed2f0ba-f01d-4ca2-a7ca-956924d350f5.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a06e0e00-5dc6-47c5-83a9-fb9954bf0bb4.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531686/75590531686.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/531686/70722531686.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/531686/67692531686_01_01_21.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/531686/5316860319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/531686/5316860318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:09:40.751Z.